The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2019 | Treating MM: the European strategy
Enrique Ocio
• 3 Jun 2019
Enrique Ocio, MD, PhD, of the University Hospital of Salamanca, Salamanca, Spain, discusses European treatment approaches in multiple myeloma, depending on a patient’s eligibility for stem-cell transplantation. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
